• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926016250
Device Problems Migration or Expulsion of Device (1395); Material Twisted/Bent (2981)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/22/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(4).  device evaluated by mfr.: the device was not returned for analysis.A review of the manufacturing documentation found that all devices shipped to this site conformed to the preventive measures / current controls as per the product specification.The investigation conclusion is caused by other device as another device/drug/subsequent procedure caused the complaint event.(b)(4).
 
Event Description
Same case as mdr id# 2134265-2018-07141 and 2134265-2018-07142.It was reported that stent damage and stent migration occurred.The 85% stenosed target lesion was located in the severely tortuous and moderately calcified ostial of the left internal mammary artery.A 2.50 x 16mm synergy ii drug-eluting stent (des) was implanted and there was ostial lesion distal so the physician tried to get the wire down because of slow flow.A non-bsc balloon catheter was advanced to post-dilate the lesion.However, after several attempts and putting multiple balloons down, the implanted stent could not be crossed with another stent.A non bsc guide extension catheter was then advanced but it got caught in the stent, deforming it and pushing the stent all the way distal.A second synergy stent was implanted inside the migrated stent and the guide extension catheter was removed.A non bsc micro-guide catheter was then introduced and a third stent implanted.The non bsc micro-guide catheter caught on the second and third stents, pushing and deforming them.The patient went to surgery and the procedure was completed.No further patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7714914
MDR Text Key114864401
Report Number2134265-2018-06575
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberH7493926016250
Device Catalogue Number39260-1625
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/02/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-